TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load.

NCT05195450 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Non-cirrhotic, Chronic Hepatitis B

Interventions

DRUG: Tenofovir alafenamide fumarate

Sponsor

Institute of Liver and Biliary Sciences, India